Steroid-resistant nephrotic focal segmental glomerulosclerosis: A treatable disease

Pediatric Nephrology

Volumn 10, Issue 6, 1996, Pages 772-778

  Tune, Bruce M ^a   Lieberman, Ellin ^b   Mendoza, Stanley A ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aggressive treatment; Steroid resistant glomerulosclerosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ARTICLE; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; PROTEINURIA;

CHILD; DRUG RESISTANCE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; NEPHROTIC SYNDROME; STEROIDS;

EID: 0029850326     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050216     Document Type: Article

References (53)

1. Churg J, Habib R, White RHR (1970) Pathology of the nephrotic syndrome in children. Lancet I: 1299-1302
2. White RHR, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet I: 1353-1359
3. Siegel NJ, Goldberg B, Krassner LS, Hayslett JP (1972) Long-term follow-up of children with steroid-resistant nephrotic syndrome. J Pediatr 81: 251-258
4. Hayslett JP, Krassner LS, Bensch KG, Kashgarian M, Epstein FH (1969) Progression of "lipoid nephrosis" to renal insufficiency. N Engl J Med 281: 181-187
5. Siegel NJ, Kashgarian M, Spargo BH, Hayslett JP (1974) Minimal change and focal sclerotic lesions in lipoid nephrosis. Nephron 13: 125-137
6. Nash MA, Bakare MA, D'Agati V, Pirani CL (1982) Late development of chronic renal failure in steroid-responsive nephrotic syndrome. J Pediatr 101: 411-414
7. Niaudet P (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J Pediatr 125: 981-986
8. McEnery PT, Alexander SR, Sullivan K, Tejam A (1993) Renal transplantation in children and adolescents, the 1992 Annual Report of the North American Pediatric Renal Transplant Co-operative Study Pediatr Nephrol 7: 711-720
9. Michielsen P (1995) Recurrence of the original disease. Does this influence renal graft failure? Kidney Int 48 [Suppl]: 79-84
10. Fahr T (1925) Pathologische Anatomie des Morbus Brightil. In: Hencke F, Lubarsch O (eds) Handbuch der speziellen pathologischen Anatomie und Histologie, vol 6. Springer, Berlin Heidelberg New York, p 222
11. Rich AR (1957) A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100: 173-186
12. McGovern VJ (1964) Persistent nephrotic syndrome: a renal biopsy study. Australas Med J 13: 306-312
13. Abramowicz M, Barnett HL, Edelmann CMJ, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo-P G, Hallman N, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. Lancet I: 959-961
14. ISKDC (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 20: 765-771
15. Habib R (1973) Focal glomerular sclerosis. Kidney Int 4: 355-361
16. D'Agati V (1994) The many masks of focal segmental glomerulosclerosis. Kidney Int 46: 1223-1241
17. Schoeneman MJ, Bennet B, Greifer I (1978) The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clin Nephrol 9: 45-54
18. Ichikawa I, Fogo A (1996) Focal segmental glomerulosclerosis. Pediatr Nephrol 10: 374-391
19. Spitzer A, Gordillo-P G, Houston IB, Travis LB (1974) Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet I: 423-427
20. ISKDC (1983) Cyclophosphamide therapy in focal segmental glomerular sclerosis: a controlled clinical trial (abstract). Eur J Pediatr 140: 149
21. Habib R, Gubler MC (1971) Les lésions glomérulaires focales des syndromes néphrotiques idiopathiques de l'enfant. Nephron 8: 382-401
22. Mongeau J-Y, Corneille L, Robitaille R O'Regan S, Pelletier M (1981) Primary nephrosis in childhood associated with focal glomerular sclerosis: is long-term prognosis that severe? Kidney Int 20: 743-746
23. Geary DF, Farine M, Thorner P, Baumal R (1984) Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Clin Nephrol 22: 109-113
24. Mongeau JG, Robitaille PO, Clermont MJ, Merouani A, Russo P (1993) Focal segmental glomerulosclerosis (FSG) 20 years later. From toddler to grown up Clin Nephrol 40: 1-6
25. Cole BR, Brocklebank JT, Kiernstra RA, Kissane JM, Robson AM (1976) "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis. J Pediatr 88: 307-314
26. Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA (1987) Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents. Nephron 46: 73-77
27. Miller JJ (1980) Prolonged use of large intravenous steroid pulses in rheumatic diseases of children. Pediatrics 65: 989-994
28. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM (1990) Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4: 303-307
29. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43: 84-88
30. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259-263
31. Gauthier BG (1987) GFR calculation beats urine collection. Pediatr Nephrol Update 1: 1
32. Waldo FB, Benfield MR, Kohaut EC (1992) Methylprednisolone treatment of patients with steroid-resistant nephrotic syndrome. Pediatr Nephrol 6: 503-505
33. Guillot AP, Kim MS (1993) Pulse steroid therapy (pst) does not alter the course of focal segmental glomerulosclerosis (FSGS) (abstract). J Am Soc Nephrol 4: 276
34. Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5: 393-397
35. Niaudet P, Broyer M, Habib R (1991) Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 35: S31-S36
36. Niaudet P, Habib R (1994) Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 5: 1049-1056
37. Melocoton TL, Kamil ES, Cohen AH, Fine RN (1991) Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 18: 583-588
38. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C (1991) The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36: 53-59
39. Lieberman KV, Tejani A (1996) A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 7: 56-63
40. Inguli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A (1995) Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5: 1820-1825
41. Hogg R (1985) Focal segmental glomerulosclerosis, in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27: 442-449
42. Habib R, Girardin E, Gagnadoux M-F, Hinglais N, Levy M, Broyer M (1988) Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular "immune deposits". Ped Nephrol 2: 402-408
43. Nash MA, Edelmann CM, Burnstein J, Barnett HL (1992) Minimal change nephrotic syndrome, diffuse mesangial hypercellu- larity, and focal glomerular sclerosis. In: Edelmann CMJ (ed) Pediatric kidney disease. Little, Brown, Boston, pp 1267-1290
44. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10: 213-218
45. Conlon PJ, Butterly D, Albers F, Rodby R, Gunnells JC, Howell DN (1995) Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am J Kidney Dis 21: 34-40
46. Detwiler RK, Falk RJ, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416-1424
47. Brown CB, Cameron JS, Turner DR, Chantler C, Ogg CS, Williams DG, Bewick M (1978) Focal segmental glomerulosclerosis with rapid decline of renal function ("malignant FSGS") Clin Nephrol 10: 51-61
48. Corwin HL, Schwartz MM, Lewis EJ (1988) The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 8: 85-89
49. Remuzzi A, Mazerska M, Gephardt GN, Novick AC, Brenner BM, Remuzzi G (1995) Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int 48: 155-162
50. Fuiano G, Comi N, Magri P, Sepe V, Balletta MM, Esposito C, Uccello F, Dal Canton A, Conte G (1996) Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis. J Am Soc Nephrol 7: 49-55
51. Barratt TM, Soothill JF (1970) Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet II: 479-482
52. Chiu J, McLaine PN, Drummond KN (1973) A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 82: 607-613
53. McCrory WW, Shibuya M, Lu W-H, Lewy JE (1973) Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. J Pediatr 82: 614-618